Evidence map›Paper›PMID 39713501›Full record

ArticleInternational journal of cardiology. Congenital heart disease2024

Incidence and correlates of mortality in adults with congenital heart disease of different age groups.

Alexander C Egbe, William R Miranda, Marwan Ahmed, Snigdha Karnakoti, Sriharsha Kandlakunta, Muhammad Eltony, Marianne Meshreky, Luke J Burchill, Heidi M Connolly

Abstract read
In one paragraph

Article in International journal of cardiology. Congenital heart disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexander C EgbeDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
William R MirandaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Marwan AhmedDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Snigdha KarnakotiDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Sriharsha KandlakuntaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Muhammad EltonyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Marianne MeshrekyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Luke J BurchillDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Heidi M ConnollyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.

Funding

Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiologyR01HL160761 · NHLBI · MAYO CLINIC ROCHESTER · PI Alexander Egbe · 2022 to 2026
$3.1M
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of FallotR01HL158517 · NHLBI · MAYO CLINIC ROCHESTER · PI EGBE, ALEXANDER · 2021 to 2025
$2.9M
NHLBI NIH HHS R01 HL158517NHLBI NIH HHS R01 HL160761
6 · The paper itself

Abstract

Background: Aging is associated with acquired comorbidities that potentially influence the natural history and outcomes of adults with congenital heart disease (CHD). The purpose of this study was to compare the clinical characteristics, as well as the incidence and correlates of all-cause mortality between different age groups. Method: Adults with CHD were categorized into 3 age groups based on age at baseline encounter: Group 1 (age 18-40 years); Group 2 (age 41-65 years), and Group 3 (age >65 years). Results: Of 5930 patients (age 37 ± 15 years), 3009 (51%), 2422 (41%), and 499 (8%) were in Groups 1, 2 and 3, respectively. Compared to Group 1, patients in Groups 2 and 3 were less likely to have complex CHD, but more likely to have acquired comorbidities, end-organ dysfunction, ventricular systolic dysfunction, and valvular heart disease. Compared to Group 1, Groups 2 and 3 had higher incidence of all-cause mortality (7.2 versus 15.3 versus 47.8 per 1000 patient-years, respectively, p < 0.001), and lower proportion of deaths from cardiovascular causes (87% versus 77% versus 71%, respectively, p < 0.001). Furthermore, the correlates of all-cause mortality were different between the age groups, with acquired comorbidities such as hypertension, coronary artery disease, and hepatorenal dysfunction being associated with mortality in Group 3, while indices of CHD severity such as number of prior cardiac surgery, and presence of complex CHD being associated with all-cause mortality in Group 1. Conclusions: These results suggest the need for management strategies tailored to address the correlates of outcomes in each age group.

Indexed as

AgeComorbiditiesCongenital heart diseasePrognostication

Identifiers

PMID39713501
PMCPMC11658335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.